SGRY
Income statement / Annual
Last year (2023), Surgery Partners, Inc.'s total revenue was $2.74 B,
an increase of 8.03% from the previous year.
In 2023, Surgery Partners, Inc.'s net income was -$11.90 M.
See Surgery Partners, Inc.,s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
FY-2018
|
FY-2017
|
FY-2016
|
FY-2015
|
FY-2014
|
| Period Ended |
12/31/2023 |
12/31/2022 |
12/31/2021 |
12/31/2020 |
12/31/2019 |
12/31/2018 |
12/31/2017 |
12/31/2016 |
12/31/2015 |
12/31/2014 |
| Operating Revenue |
$2.74 B
|
$2.54 B
|
$2.23 B
|
$1.86 B
|
$1.83 B
|
$1.77 B
|
$1.34 B
|
$1.15 B
|
$959.89 M
|
$403.29 M
|
| Cost of Revenue |
$2.10 B |
$1.96 B |
$1.73 B |
$1.48 B |
$1.41 B |
$1.36 B |
$1.01 B |
$821.20 M |
$669.33 M |
$254.18 M |
| Gross Profit |
$647.50 M |
$574.90 M |
$491.40 M |
$379.80 M |
$423.80 M |
$410.03 M |
$327.42 M |
$324.24 M |
$290.57 M |
$149.11 M |
| Gross Profit Ratio |
0.24 |
0.23 |
0.22 |
0.2 |
0.23 |
0.23 |
0.24 |
0.28 |
0.3 |
0.37 |
| Research and Development
Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| General & Administrative
Expenses |
$120.90 M
|
$102.20 M
|
$104.00 M
|
$97.10 M
|
$88.60 M
|
$93.56 M
|
$75.95 M
|
$60.25 M
|
$55.99 M
|
$31.45 M
|
| Selling & Marketing
Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Selling, General &
Administrative Expenses |
$120.90 M
|
$102.20 M
|
$104.00 M
|
$97.10 M
|
$88.60 M
|
$93.56 M
|
$75.95 M
|
$60.25 M
|
$55.99 M
|
$31.45 M
|
| Other Expenses |
$0.00 |
$112.40 M |
$60.90 M |
$48.60 M |
$75.10 M |
$63.67 M |
$25.33 M |
-$3.73 M |
-$119.91 M |
$21.21 M |
| Operating Expenses |
$319.50 M |
$214.60 M |
$164.90 M |
$145.70 M |
$163.70 M |
$157.23 M |
$156.37 M |
$123.66 M |
$111.83 M |
$52.66 M |
| Cost And Expenses |
$2.42 B |
$2.18 B |
$1.90 B |
$1.63 B |
$1.57 B |
$1.52 B |
$1.17 B |
$944.85 M |
$781.16 M |
$306.84 M |
| Interest Income |
$0.00 |
$227.00 M |
$220.90 M |
$201.80 M |
$178.90 M |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
| Interest Expense |
$193.00 M |
$234.90 M |
$221.00 M |
$201.80 M |
$178.90 M |
$147.00 M |
$117.67 M |
$100.57 M |
$100.98 M |
$62.10 M |
| Depreciation &
Amortization |
$118.10 M
|
$149.60 M
|
$137.90 M
|
$134.20 M
|
$116.50 M
|
$67.44 M
|
$51.93 M
|
$39.55 M
|
$34.55 M
|
$15.06 M
|
| EBITDA |
$480.80 M
|
$460.00 M
|
$401.00 M
|
$277.80 M
|
$336.60 M
|
$144.68 M
|
$251.88 M
|
$245.23 M
|
$59.39 M
|
$65.87 M
|
| EBITDA Ratio |
0.18 |
0.2 |
0.2 |
0.18 |
0.19 |
0.19 |
0.19 |
0.21 |
0.1 |
0.28 |
| Operating Income Ratio
|
0.12
|
0.14
|
0.14
|
0.13
|
0.13
|
0.04
|
0.12
|
0.17
|
0.15
|
0.13
|
| Total Other
Income/Expenses Net |
-$193.00 M
|
-$234.90 M
|
-$221.00 M
|
-$201.80 M
|
-$181.30 M
|
-$147.00 M
|
-$75.95 M
|
-$104.30 M
|
-$220.89 M
|
-$62.10 M
|
| Income Before Tax |
$135.00 M |
$110.30 M |
$81.20 M |
-$18.80 M |
$54.60 M |
-$69.17 M |
$82.29 M |
$92.18 M |
-$76.14 M |
-$11.29 M |
| Income Before Tax Ratio
|
0.05
|
0.04
|
0.04
|
-0.01
|
0.03
|
-0.04
|
0.06
|
0.08
|
-0.08
|
-0.03
|
| Income Tax Expense |
$300,000.00 |
$23.30 M |
$10.50 M |
-$20.10 M |
$8.50 M |
$26.46 M |
$53.55 M |
$7.10 M |
-$148.98 M |
$15.76 M |
| Net Income |
-$11.90 M |
$87.00 M |
$70.70 M |
$1.30 M |
$46.10 M |
-$205.71 M |
-$52.99 M |
$9.45 M |
$1.43 M |
-$65.90 M |
| Net Income Ratio |
-0 |
0.03 |
0.03 |
0 |
0.03 |
-0.12 |
-0.04 |
0.01 |
0 |
-0.16 |
| EPS |
-0.0947 |
0.95 |
0.98 |
0.0267 |
0.95 |
-4.28 |
-1.09 |
0.2 |
0.04 |
-1.37 |
| EPS Diluted |
-0.0947 |
0.95 |
0.98 |
0.0267 |
0.95 |
-4.28 |
-1.08 |
0.2 |
0.04 |
-1.37 |
| Weighted Average Shares
Out |
$125.61 M
|
$91.95 M
|
$72.43 M
|
$48.78 M
|
$48.28 M
|
$48.03 M
|
$48.69 M
|
$48.02 M
|
$36.07 M
|
$48.16 M
|
| Weighted Average Shares
Out Diluted |
$125.61 M
|
$91.95 M
|
$72.43 M
|
$48.78 M
|
$48.28 M
|
$48.03 M
|
$49.00 M
|
$48.19 M
|
$37.46 M
|
$48.16 M
|
| Link |
|
|
|
|
|
|
|
|
|
|
